Department of Biochemistry, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad 45320, Pakistan.
Center for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha 410083, China.
Medicina (Kaunas). 2023 Feb 16;59(2):379. doi: 10.3390/medicina59020379.
: Mutations in the gene cause reduced NADH-dependent cytochrome b5 reductase enzyme function and consequently lead to recessive congenital methemoglobinemia (RCM). RCM exists as RCM type I (RCM1) and RCM type II (RCM2). RCM1 leads to higher methemoglobin levels causing only cyanosis, while in RCM2, neurological complications are also present along with cyanosis. : In the current study, a consanguineous Pakistani family with three individuals showing clinical manifestations of cyanosis, chest pain radiating to the left arm, dyspnea, orthopnea, and hemoptysis was studied. Following clinical assessment, a search for the causative gene was performed using whole exome sequencing (WES) and Sanger sequencing. Various variant effect prediction tools and ACMG criteria were applied to interpret the pathogenicity of the prioritized variants. Molecular dynamic simulation studies of wild and mutant systems were performed to determine the stability of the mutant CYB5R3 protein. : Data analysis of WES revealed a novel homozygous missense variant NM_001171660.2: c.670A > T: NP_001165131.1: p.(Ile224Phe) in exon 8 of the gene located on chromosome 22q13.2. Sanger sequencing validated the segregation of the identified variant with the disease phenotype within the family. Bioinformatics prediction tools and ACMG guidelines predicted the identified variant p.(Ile224Phe) as disease-causing and likely pathogenic, respectively. Molecular dynamics study revealed that the variant p.(Ile224Phe) in the CYB5R3 resides in the NADH domain of the protein, the aberrant function of which is detrimental. : The present study expanded the variant spectrum of the gene. This will facilitate genetic counselling of the same and other similar families carrying mutations in the gene.
: 基因中的突变导致 NADH 依赖性细胞色素 b5 还原酶功能降低,从而导致隐性先天性高铁血红蛋白血症(RCM)。RCM 分为 RCM1 型和 RCM2 型。RCM1 导致高铁血红蛋白水平升高,仅导致发绀,而在 RCM2 中,除了发绀外,还存在神经并发症。 : 在目前的研究中,研究了一个来自巴基斯坦的有血缘关系的家庭,其中有三个人表现出发绀、向左臂放射的胸痛、呼吸困难、端坐呼吸和咯血的临床症状。经过临床评估,使用全外显子组测序(WES)和 Sanger 测序对致病基因进行了搜索。应用各种变异效应预测工具和 ACMG 标准来解释优先变异的致病性。对野生和突变系统进行分子动力学模拟研究,以确定突变 CYB5R3 蛋白的稳定性。 : WES 数据分析显示,在位于 22q13.2 染色体上的基因的外显子 8 中,存在一个新的纯合错义变异 NM_001171660.2:c.670A > T:NP_001165131.1:p.(Ile224Phe)。Sanger 测序验证了在该家庭中,鉴定的变异与疾病表型的分离。生物信息学预测工具和 ACMG 指南预测,鉴定的变异 p.(Ile224Phe)分别为致病和可能致病。分子动力学研究表明,CYB5R3 中的变异 p.(Ile224Phe)位于该蛋白的 NADH 结构域,其异常功能是有害的。 : 本研究扩展了 基因的变异谱。这将有助于携带 基因突变的相同和其他类似家庭的遗传咨询。